Cardiff Oncology Inc (CRDF) Stock Analysis

Cardiff Oncology Inc (CRDF) is a publicly traded company in the HEALTHCARE sector. It trades at $1.51, carries a market capitalization of $101.19M. This page summarizes the public market data, fundamentals, and frequently asked questions for CRDF, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.51
• Market Cap: $101.19M
• EPS: $-0.67
• 52-Week High: $4.56
• 52-Week Low: $1.40

Market Sentiment

Cardiff Oncology Inc currently has a Neutral sentiment score of 0.07.

About Cardiff Oncology Inc

Cardiff Oncology, Inc. is a clinical-stage biotechnology firm headquartered in San Diego, California, specializing in the development of innovative, targeted therapies for cancer treatment. Utilizing its proprietary technology platform, the company is committed to advancing a robust pipeline of drug candidates aimed at improving patient outcomes across various malignancies. With a focus on addressing unmet medical needs in oncology, Cardiff Oncology is well-positioned to make impactful contri...

GNG Research Analysis

GNG Research scores Cardiff Oncology Inc (CRDF) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CRDF.

Frequently Asked Questions

Does CRDF pay dividends?

Cardiff Oncology Inc (CRDF) does not currently pay a regular dividend.

What is CRDF's market cap?

Cardiff Oncology Inc (CRDF) has a market capitalization of $101.19M with a current stock price of $1.51.